Abstract
Background: Corona virus disease 2019 (COVID-19) is a communicable disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It was first identified in December 2019 in Wuhan, China, and has since spread globally, leading to an ongoing pandemic.
 Aim of study: to review the clinical, lab investigation and imaging techniques, in pediatric age group affected COVID-19 to help medical experts better understand and supply timely diagnosis and treatment.
 Subjects and methods: this study is a retrospective descriptive clinical study. The medical records of patients were analyzed. Information’s recorded include demographic data, exposure history, symptoms, signs, laboratory findings, chest x- ray, and chest computed tomographic (CT) scans. Data were obtained with data collection forms from paper medical records.
 Results: there were 76 COVID-19 pediatric patients, 46.1% of those patients were within the age group 6 -10 years. The female to male ratio was 1:1, and 92.1% of them were living within the urbane area. About 60.5% of patients were pupils. Seventy-one (93.4%) patients of them had no comorbidity. Twenty (26.3%) patients were asymptomatic. Regarding the duration of hospital stay, 39(51.31) patients had <7 days. All of the patients were nonsmokers. All patients had recovered and discharged from hospital after 2 negative real technique-polymerase chain reaction (RT-PCR) tests, no death was reported. Only 16(21.1%) patients had severe symptoms.
 Conclusions: the most common symptoms were fever, Cough, Loss of appetite, Shortness of breath & Fatigue. There was a statistically significant association between white blood cells counts, neutrophil number, Chest X-Ray results, with case severity and a statistically significant association between form of treatment in patients who received Oxygen, Oseltamivir, Azithromycin, Paracetamol, Dexamethasone, and case severity.
Highlights
Corona virus disease 2019 (COVID-19) is a communicable disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
COVID-19 and have a milder disease than adults; this result was constant with other studies [17,18,19,20], since all patients recovered with no complication and no death was reported
21.1% of patients had severe symptoms, while Dong Y., et al, early study of pediatric patients with COVID-19 infection reported that children develop a comparatively mild disease course with 83% of confirmed cases presenting with mild to moderate infection, with a further 13% being asymptomatic, and only 3% presenting with severe and critical illness, [19]
Summary
A retrospective descriptive clinical study, there were 76 confirmed hospitalized cases of COVID-19 between 24th February and August. Patients enrolled during this study were diagnosed by a positive PCR test for COVID-19 and treatment plan for the new coronavirus infection formulated by Iraqi ministry of health had been tried [10,11]. Nasopharyngeal swab, and blood sample, specimens were collected from patients with suspicion of COVID-19. To mention that the patient is recovered, (RT-PCR) tests results were collected at the end of the treatment, nasopharyngeal and throat specimens were obtained from patients by using specific kits by a professional health-staff and sent to the Central Public Health. The patient wasn't discharged until two PCR-tests were negative at least 24 hours apart, according to the WHO interim guidance, 13 March 2020, clinical management of severe acute respiratory tract infection. Hospital administration with a clarification on the purpose of the research before the research was started
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
